These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 27721531)
1. Are therapeutic vaccines an answer to the global problem of drug and alcohol abuse? Brashier DB; Sharma AK; Akhoon N Indian J Pharmacol; 2016; 48(5):487-489. PubMed ID: 27721531 [TBL] [Abstract][Full Text] [Related]
2. Ethical Implications in Vaccine Pharmacotherapy for Treatment and Prevention of Drug of Abuse Dependence. Carfora A; Cassandro P; Feola A; La Sala F; Petrella R; Borriello R J Bioeth Inq; 2018 Mar; 15(1):45-55. PubMed ID: 29350320 [TBL] [Abstract][Full Text] [Related]
3. Anti-drug vaccines to treat substance abuse. Kinsey BM; Jackson DC; Orson FM Immunol Cell Biol; 2009; 87(4):309-14. PubMed ID: 19333250 [TBL] [Abstract][Full Text] [Related]
4. Vaccines against drugs of abuse: a viable treatment option? Kantak KM Drugs; 2003; 63(4):341-52. PubMed ID: 12558457 [TBL] [Abstract][Full Text] [Related]
7. The future of vaccines in the management of addictive disorders. Orson FM; Kinsey BM; Singh RA; Wu Y; Gardner T; Kosten TR Curr Psychiatry Rep; 2007 Oct; 9(5):381-7. PubMed ID: 17915077 [TBL] [Abstract][Full Text] [Related]
8. Animal Models and the Development of Vaccines to Treat Substance Use Disorders. Ohia-Nwoko O; Kosten TA; Haile CN Int Rev Neurobiol; 2016; 126():263-91. PubMed ID: 27055616 [TBL] [Abstract][Full Text] [Related]
10. Immunotherapy for the treatment of drug abuse. Kosten T; Owens SM Pharmacol Ther; 2005 Oct; 108(1):76-85. PubMed ID: 16023218 [TBL] [Abstract][Full Text] [Related]
11. Current status of vaccines for substance use disorders: A brief review of human studies. Truong TT; Kosten TR J Neurol Sci; 2022 Mar; 434():120098. PubMed ID: 34952345 [TBL] [Abstract][Full Text] [Related]
12. Is immunotherapy an opportunity for effective treatment of drug addiction? Zalewska-Kaszubska J Vaccine; 2015 Nov; 33(48):6545-51. PubMed ID: 26432911 [TBL] [Abstract][Full Text] [Related]
13. [Immunotherapies for drug addictions]. Montoya I Adicciones; 2008; 20(2):111-5. PubMed ID: 18551223 [TBL] [Abstract][Full Text] [Related]
14. Development of immunopharmacotherapy against drugs of abuse. Meijler MM; Matsushita M; Wirsching P; Janda KD Curr Drug Discov Technol; 2004 Jan; 1(1):77-89. PubMed ID: 16472221 [TBL] [Abstract][Full Text] [Related]
15. Development of vaccines to help treat drug dependence. Bunce CJ; Loudon PT; Akers C; Dobson J; Wood DM Curr Opin Mol Ther; 2003 Feb; 5(1):58-63. PubMed ID: 12669472 [TBL] [Abstract][Full Text] [Related]
16. The continuing search for an addiction vaccine. Ozgen MH; Blume S Vaccine; 2019 Aug; 37(36):5485-5490. PubMed ID: 31266675 [TBL] [Abstract][Full Text] [Related]
17. Psychopharmacology: neuroimmune signaling in psychiatric disease-developing vaccines against abused drugs using toll-like receptor agonists. Yang F; Kosten TR Psychopharmacology (Berl); 2019 Oct; 236(10):2899-2907. PubMed ID: 30726515 [TBL] [Abstract][Full Text] [Related]
19. Current status and future prospects for the development of substance abuse vaccines. Heekin RD; Shorter D; Kosten TR Expert Rev Vaccines; 2017 Nov; 16(11):1067-1077. PubMed ID: 28918668 [TBL] [Abstract][Full Text] [Related]
20. Optimization of a methamphetamine conjugate vaccine for antibody production in mice. Stevens MW; Gunnell MG; Tawney R; Owens SM Int Immunopharmacol; 2016 Jun; 35():137-141. PubMed ID: 27039212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]